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Skin tumors induced in mice by chronic exposure to 
UVE radiation are often highly antigenic and regress 
w-hen transplanted into normal syngeneic animals, but 
groW' progressively in immunosuppressed mice. Expo-
sure of mice to subtumorigenic doses of UVB radiation 
can abolish this immunologic rejection phenomenon. In 
this study, we have investigated the effects of treatment 
vvith 8-methoxypsoralen plus UV A radiation (PUV A) on 
the rejection of antigenic UVB-induced tumors. PUV A 
treatment, with either topical or systemic administration 
of the psoralen, did not alter the normal process of 
rejection ofUVB-induced tumors. Mice treated with both 
minimally and markedly phototoxic doses of PUV A re-
jected tumors with a frequency similar to that seen in 
untreated animals, although these tumors grew progres-
sively in UVB-irradiated mice. These results indicate 
that the effects of PUV A treatment differ from those of 
UVB irradiation in that PUV A treatment does not alter 
the immunologic rejection of UVB-induced tumors. 
In mice, many tumors induced by exposUJ"e to UVB (290-320 
nm) radiation a re highly a ntigenic in that they regress upon 
transplantation into normal syngeneic mice [1 ,2]. This r ej ection 
phenomenon is mediated by a cellular immune response [1,3]. 
However, exposure of animals to a subtumorigenic dose of UVB 
radiation results in a systemic alteration so that they are no 
longer a ble to reject highly antigenic UVB-induced tumors [3-
5]. This systemic alteration r esults from t h e development of 
suppressor T lymphocytes that sp ecifically inhibi t t h e r ej ection 
of UV -induced t umors, thus rendering the animals susceptible 
to tumor growth [4,6-8]. The relevance of these findings to m a n 
is unknown. However, t h e incr eased inciden ce of squa mous cell 
carcinomas in immunosuppressed renal transplant recipients 
[9-12] is suggestive evide nce that the immune system m ay be 
involved in huma n photocarcinogenesis. 
R ecently, inter est has been fo cused o n the tumorigenic po-
tential of exposure to UVA (320-400 nm) radia tio n following 
administration of the chemical photosensitizer, 8-meth oxy psor-
alen (methoxsalen). This combined t reatment, commonly r e-
ferred to by the acronym, PUV A, is t umorigenic in a nimals 
[13,14] and possibly contributes to the development of squa-
mous cell car cinomas in m a n [15]. Thus, in addition to elicit ing 
many simila r biologic r esponses in t h e skin, PUV A and UVB 
treatm en t also seem to share t h e property of being car cinogenic 
in man a nd animals . I t was, t h erefore, of interest to de termine 
whether PUV A treatment m ediated th e sam e alteration in 
immunologic r eactivity as that induced by UVB radiation. 
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MATERIALS AND METHODS 
Mice 
Specific pathogen-free female mice of the inbred strain C3H/ 
HeN(MTV- ) (C3H - ) and athymic nude mice (nu / nu) on a random-
bred Swiss background (N. NIH(S)) were supplied by the Frederick 
Cancer Research Center's Animal Production Area. Animals were 6 to 
8 weeks old at the star t of experiments. They were given free access to 
chlorinated water (10-1 2 ppm) and P urina Mouse Chow and were 
housed in rooms where ambient light was automatically regulated on 
a 12-hj' light-dark cycle. 
PUVA Trea.tment 
Methoxsalen was administered either by in traperi toneal (i. p.) injec-
tion of 0.4 mg (Hoffman-LaRoche, Inc., Nutley, NJ; 0.5 ml of a 0.8 mg/ 
ml solu t ion of drug in saline plus 0.5% carboxymethyl ceLlulose) or 
top ical application of 0.05 mg (Paul B. E lder , Co., Bryan, OH; 50lU of 
1 mg/ml solu tion of drug in 30% acetone and 70% ethyl alcohol). One 
hour after drug administration, the animals were exposed to UV A 
radiation provided by the output of a bank of 6 PUV A fluorescent 
bulbs (Sylvania, Danvers, MA) fil tered through 0.5 mm mylar to 
eliminate wavelengths shor ter than 320 nm. The spectra l i.rrad iance of 
the source was measured with a cosine-corrected UV spectroradiometer 
system (International Light, Inc., IL7oo, Newburyport, MA) , and mea-
surements of the irradiance were made for t.he in tegrated 320-400 nm 
band wi th a WBS 350 SEE 400 detector. T he irrad iance of the source 
was in the range of 10- 12.5 J / m2/ sec. 
PUVA treatments were administered 5 times per week. The mice 
were housed 5/cage on a shelf 20 cm below the flu orescent bu lbs. T he 
cages were systematically rotated before each treatment to compensate 
for any variation of the i.rradiance along the shelf. T he mice were 
shaved weekly with Oster electric cl ippers wi th a No. 40 blade. Dorsal 
hair was removed from the base of the ta il to the nape of the neck and 
to the late ral miclJines. The animals were examined weekly for evidence 
of phototoxicity, and the exposed skin of the back of representative 
animals was biopsied after 3 and 6 weeks of trea tment. The skin 
biopsies were fixed in Bouin 's solution and, following embedding and 
sectioning, were stained with hematoxylin and eosin for microscopic 
examination. 
UIIB Radiation 
Exposure to UVB radiation was provided by a bank of 6 FS40 
sunlamps (Westinghouse, Bloomfield, NJ) . T he spectral i.rrad iance of 
the source was measured wi th the a noncosine-correcting Hewli Lt-
Packard radiant flu x detector (Model 8344 A) , having a sensitivity of 
O:l,u V / u W / cm". The average in adiance of the source was apPl:oxi-
mately 2 J / m2/sec. The condi tions for preparation, exposure, housing, 
and examination of the animals were the same as fo r the PUV A-treat.ed 
mice. 
Imnwnosuppression 
C3H- mice were immunosuppressed by thymectomy a t. 4-5 weeks of 
age, fo llowed by whole-body exposure to 450 R of X-in adiation from a 
Phillips MG 301 X-ray unit, 24 hr prior to tumor t ransplantation (2-4 
weeks a fter thymectomy). These animals ar e referred t.o as ATX mice. 
Tumor Induction 
Beginning at 8 weeks of age, mice were treated with UVB radiation 
(7.2 x 10" J / m2) 3 times per week. Treatment. was continued un ti l an 
animal developed a tumor of sufficient ize (approximately 10 mm in 
diameter) for biopsy and t ransplantation. T umor biopsies were fixed in 
Bouin's solu tion, embedded, sectioned and stained with hematoxylin 
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and eosin for microscopic examination. UVB-induced fi brosarcomas 
UV-2240 and UV-2237 clone 46 were established and maintained as 
tissue culture lines as described prev iously [16). 
Tumor Challenge 
Tumor ceUs were injected s.c. on the ventral side near the inguinal 
region of each recipient 2 days after the last exposure to UVB radiation 
or PUV A treatment. The recipients were examined weekly, and tumor 
sizes were recorded. Observations were continued until there was 
evidence of progressive growth of the tumor (4-12 weeks). The in vitro-
passaged tumor lines were harvested by 1 min trypsinization as de-
scribed earlier [161. All tumors used in this study were tested routinely 
for and found to be free of Mycoplasma, and the following mur ine 
viruses: reovirus type 3, pneumonia virus of mice, K virus, Theiler's 
encephalitis virus, Sendai virus, minute virus of mice, mouse adenovi-
rus, ectromelia virus, and lactate dehydrogenase virus. 
Statistical Analysis 
Differences in tumor incidence between the groups of animals were 
tested for significance using Yates' correction of the Chi-square Test 
[171-
RESULTS 
Growth of UVB-induced Fibrosarcomas in PUVA-treated 
Mice 
Groups of mice were treated i.p. with methoxsalen followed 
by various doses of UV A radiation for a period of 3 weeks. The 
a nimals were th en challenged with cells of a UVB-induced 
tumor and observed for tumor growth over the next 7 weeks. It 
can be seen in the Figure that only 30-50% of the PUV A-
treated mice developed tumors and that this level of tumor 
susceptibility did not differ significantly (P > 0.05) from that 
exhibited by untreated a nimals. However, a ll mice treated with 
UYB radiation for 8 weeks and immunosuppressed (ATX) mice 
deve loped tumors by the third week of observation , as would 
be predicted (Tom previous studi es [3-5]. 
A 2nd , more extensive experiment produced similar results 
(Table I). Mice treated with PUVA, UYA radiation alone, or 
methoxsale n alo'ne for 6 weeks and then challenged with cells 
of a UVB-induced fibrosarcoma (UV-2237 Clone 46) developed 
few tumors during the subseq uen t 4-week observation period. 
In contrast all mice treated with UYB radiation for 12 weeks 
and athymic nude m ice developed tumors within 2 weeks of 
challenge. The resul ts were similar following challenge with a 
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Week s Aft er Challenge 
Gl"Owth of a UVB-induced fibrosarcoma in PUVA-treated mice. 
Cumulative tumor incidence in syngeneic C3H female mice challenged 
s.c. with 1 X lOt; UVB-2237 Clone 46 fibrosarcoma cells, 2 days after 
last treatment. Treatment groups: 0.4 mg melhoxsalen i.p. fo llowed by 
3 x 10" Ji m" (0--0), 9 x 10" J / m2 (._...), or 2.7 X 10" Ji m" 
(0 -- ---0 ) of UV A rad iation 5x/weck for 3 weeks; UVB radiation 
(e----e) (7.2 x 10" Ji m' ) 3X/ week for 8 weeks; thymectomy and X-
irradiation (e-----e ); no treallllent (0-0). 
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second UVB-induced fibrosarcom a cell line (UV -2240) , in that 
none of the mice treated with systemic PUV A for 6 weeks 
developed tumors, whereas almost all of the UVB-treated mice 
had palpable tumors within 4 weeks of challenge. 
The influence of the route of administration of methoxsalen 
was t hen examined. The results are summarized in T a ble II. 
S ix weeks after challenge with UYB-induced fibrosarcoma cells, 
t he incide nce of tumors in mice treated with topical or i.p . 
methoxsalen and 2 different doses of UY A rad iation did not 
differ s ignificantly from that of untreated a nimals (P > 0.05). 
As in the prev ious experiments, however, all ofthe UVB-treated 
and immunosuppressed mice developed tumors within 2 weeks 
of challe nge. 
Photo toxicity of PUVA and UVB Regimens 
Mice from the sam e treatment groups as t hose used in th e 
prev ious experiment (Table II) were examined after 3 a nd 6 
weeks of PUV A and UYB treatment for gross and hjstologic 
ev idence of phototoxicity. In mice treated with systemic m eth -
oxsalen a nd UV A radiation for 3 weeks, the photo toxic response 
of the skin varied with the dose ofUVA rad iation: 9 X 10:3 J / m2 
5X/week produced necrosis of the skin of the back a nd pigmen-
tation; 2.7 X 10'1 J / m2 5x/week produced marked necrosis and 
scarring on the back, plus loss of tissue from the ears. Topical 
methoxsalen a nd UV A radiation treatment was somewhat less 
phototoxic but, at the highest UY A dose, necrosis a nd incr eased 
pigmentation wer e readily a pparent. After 3 weeks of treatment, 
th e phototoxici ty in mice treated with the highest dose of UV A 
radiation with either i.p. or s.c. methoxsalen was considerably 
greater t ha n t hat seen in animals treated with UVB radiation. 
After 6 weeks of treatment, this pattern was even more exag-
gerated; the amount of skin damage continued to increase in 
the UV A-treated groups, but rema ined stable or decreased in 
the UVB-treated a nimals. 
H istologic examina tion of biopsies of back skin from repre-
sentative a nima ls confirmed these morphologic observations. 
The most marked ch a nges were seen in skin sections from 
a nimals treated with systemic methoxsalen and 2.7 X 104 J / m2 
UV A 5x/week. These sections showed hyperkeratosis, acan-
thosis, ma ny pyknotic cells in the epidermis, a marked infla m-
matory cell inftltrate involving epidermis, dermis, a nd s.c. adi-
pose t issue, plus areas of ulceration; these cha nges were present 
after 3 weeks of irradiat ion a nd , a fter 6 weeks of irradiation, 
they were even more marked. Systemic methoxsalen with 9 X 
10'1 J /m~ UVA radiation, a nd topical methoxsale n with 2.7 X 
10" J /m~ UVA produced similar cha nges, but to a lesser degree; 
however, topical methoxsalen plus UY A did not produce per-
turbations in the s.c. t issues. The microscopic evidence of 
photoxicity following 5.4 X 10'3 J / m2 of UVB radiation 5x/week 
for 6 weeks was much less pronounced that that seen with 
PUVA. T his treatment produced moderate hyperkera tosis and 
acanthosis, a n inflammatory cell infiltrate in the dermis, but 
little involvement of the ad ipose tissue a nd no evidence of 
ulceration . Thus, the PUYA treatments were actually more 
photo toxic than t he UVB exposures, even though these PUY A 
treatments fa iled to enhance the growth of UVB-induced tu-
mors. 
DISCUSSION 
Prev ious studies [1,2] havp demonstrated that in C3H- mice 
most UVB-induced tumors are rejected when transpla nted into 
normal syngeneic recipients, but grow progressive ly in immu-
nosuppressed a nimals. FUl"thermore, exposure of mice to sub-
tumorige!1ic doses of UVB radiation results in a specific sys-
temic alteratio n rendering the a nimals unable to reject trans-
planted UYB-induced tumors that are rejected by normal syn-
geneic hosts [3-5], although they can reject allogeneic tissues 
[3,18]. This state of heightened tumor susceptibility is accom-
pa nied by the appearance of suppresso r T lymphocytes in the 
lymphoid t issue of mice, resu lting from their exposure to UYB 
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TABL E 1. Growlh of UVB ·induccd fibrosarcomw; in P UVA· or UVB·trealed syngeneic mice 
Cha llenge t Ull10r 
U V -2237 Clone 46 
( 1 x 10" cells s.c.) 
UV-2240 
(1 x 10" cells s.c. ) 
1 'rea tment groups" 
PUVA 
UVA 
Methoxsalen 
UVB 
Nude Mice 
No trcatmenL 
PUVA 
UVB 
ATX 
No treatment 
0/ 0 
2/ 10 
0/ 10 
l/IO 
0/ 5 
1/ 20 
0/ 9 
0/ 10 
0/ 5 
0/ 19 
Cumulative Lumor incidence" at wee k: Final 
of incidence 
1/ 9 1/ 9 0/ 9 0 
1/ 10 1/ 10 1/ 10 10 
0/ 10 0/ 10 0/ 10 0 
10/ l0 100 
5/ 5 100 
2/ 20 1/ 20 1/ 20 5 
0/ 9 0/ 9 0/ 9 0 
0/ 10 6/ 10 9/ 10 90 
0/ 5 1/ 5 2/5 40 
0/ 19 0/ 19 0/ 19 0 
a PUVA = 004 mg methoxsalen i.p. and 9 x 10" J / m' UVA 5x/ week for 6 weeks; UVA = 9 x 10" J / m" UVA 5x/ week for 6 weeks; methoxsalen 
= 9.4 mg in 0.5 ml i.p. 5x/week for 6 weeks; UVB = 7.2 x 10" J / m" 3x/ week for 12 weeks; ATX = adult thymectomy + 450 R X·irradiation. 
, Number of' mice with palpable tumor/ number challenged. 
TAB I_E II. Growth of a UVB·induced fibrosarcoma ill C3H - mice treated topically or systemically with metho.rsa /ell fa/lowed by UVA 
rodiation 
Cumul a tive tum or in cici ence" at wee k: Finnl Trea tmenl groupsfl 
5 Of> incidence 
Topical mcthoxsa len and : 
9x 10:1 J / m" UV A 0/ 10 1/ 10 1/ 10 2/ 10 2/ 10 2/ 10 20 
2.7 X 10" J / m' UVA 0/ 10 2/ 10 0/ 10 0/ 10 0/ 10 0/ 10 0 
i.p . rnethoxsalen and: 
9 x 10" J / m' UVA 0/10 3/ 10 3/ 10 3/ 10 3/ 10 3/ 10 30 
2.7 x 10" J / m" UVA 0/ 10 l/1O 2/ 10 3/ 10 3/ 10 4/ LO 40 
5.4 x 10" J / m' UVB 0/ 10 10/ 10 100 
ATX 0/ 5 5/ 5 100 
N o t r eat.ment. 0/ 10 2/ 10 2/ 10 2/ 10 2/ 10 2/ 10 20 
" PUVA and UVB treat.ments were administ.ered 5x/ week for 6 weeks. Topical met.hoxsa len = 0.05 mg in 50 rd; i.p. methox alen = 0.4 mg in 
0.5 rnl. ATX ;= immunosuppression by adu lt t.hymectomy and sublet.hal (450 R) X·irradiation. 
" Number of' mice wit.h palpable t.umor/ number challenged s.c. wit.h 1 x 10" cells of UVB-induced fibrosarcoma UV-2237 Clone 46. 
radiation L 4,0-8]. In the present s tudy , this sys temic alter atio n 
of immune r esponsivenes was demonstrated by the develop-
m e nt of t umors in almost all UVB-treated animals, following 
challenges with cells derived f1'om 2 UVB-induced fibrosarco-
mas. In contrast, exposure of mice to subtumorigenic doses of 
PUV A did not render them susceptible to the growth of UVB-
induced tumors. The incidence and growth rate of these tumors 
did not differ statistically in PUV A-treated mice a nd in un -
treated animals. Even with doses of PUVA that produced 
substantially more skin damage than that observed following 
UVB i_rradiation, the animals were not rendered susceptible to 
challenge with UVB-induced tumors. 
These conclusions are in direct contrast to those reported 
recently by Roberts, Schmitt and Daynes [19]. These investi-
gators concluded that PUVA treatment, like UVB treatment, 
converted C3H mice to a state of susceptibility for the growth 
of UVB-induced tumors. Because our experiments wi th i.p.-
administered methoxsalen and UV A were at vaJ'iance with this 
report, we compared our regimen wi th that of Roberts, Schmitt, 
and Daynes in which topical methoxsalen had been used . Using 
an experimental protocol that closely approximated that re-
ported [19], we detected no increase in t he susceptibility of 
PUV A-treated mice to UVB-induced tumors (Table II). 
There are several possible explanations for this discrepancy. 
First, it is possible that the growth of UVB- induced tumors in 
PUV A-treated mice observed by Roberts, Schmitt, and Daynes 
[19] was caused by the general debili tation of the animals 
following PUV A treatment. In our experiments, there was a 
suggestion that extreme phototoxicity might resul t in incr eased 
tumor growth. Although there was no statistically significant 
increase in tumor incidence in PUV A-treated mice in anyone 
experiment, in 2 experiments [Figure and T able II] the animals 
receiving the most phototoxic PUVA treatments had higher 
tumo)' incidences than the untreated animals. However, if these 
exp eriments had been calTied out in mice that were not path-
ogen-free, it is possible that furth er immullologic debili tation, 
secondary to the PUV A t reatment, could occur from infectious 
disease; such a problem could be of ufficient magnitude to 
permit tumor gr owth . Becau e the a nimals and tumors used by 
Robert, Schmitt, and Daynes were not defined as to their 
microbial and viral status, a nd the degree of phototoxicity of 
the animals was not described [J 9], t hese possible explanations 
for the differ ence in results cannot be ruled out at present. 
Another difference bet.ween these 2 st.udies is t hat the UVA 
source employed by Roberts, chmitt, and Daynes [19] emit 
a significant amount of radia tion in the UVB range «320 nm ), 
whereas in our experiments, a mylar fil te r was used to eliminate 
contaminating UVB radiation from the light source. An esti-
mate of the UVB dose delivered by the unfil tered la mps, 
calculated from the reported data [19] and from the emission 
spectrum of General E lectric F40BL bulbs, suggests that the 
animals in t hat st.udy could have received as much as 5.6 x 10" 
J';m~ of UVB radiation during the course of a n experim ent. 
Although this was not enough UVB to cause tumor suscepti-
bility alone, as "UVA-treated" cont rol animals were tumor-
resistant, in combination with a small amount of nonspecifi c 
immunosuppression (i. e., from the phototoxic effect.s of PUVA 
t reatment or microbial or viral contami nation of the t.umor 
tissue), this may have been sufficient to tip the balance in favor 
of tumor growth. Thus, the enhanced growth of UVB-i nduced 
tumors in PUVA-treated mice observed by Roberts, Schmi tt, 
and Daynes [19] could be caused by nonspecific mecha nisms 
unrelated to the induction of the suppressor T cells that a re 
responsible for the growth of these tumors in UVB-trea ted 
animals [4,6-8]. The fact that suppressor lymphocytes could 
not be demonstrated in the tumor-susceptible PUV A-treated 
mice [19] strongly supports this possibiJi ty that different mech-
anisms are involved. 
Recent experiments on the mechanism of UVB-ind uced sus-
ceptibility to challenge with UVB-induced tumors suggest that 
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suppressor cell induction by UVB radia tion resul ts from at least 
2 distinct effects of the radiation. Fil'st, ther e is the induction of 
an alteration in a ntigen-presenting cell function in UVB-il'fa -
diated mice that shifts the immunologic pathway toward sup-
pressor , rather than effector cell induction [20). Second, there 
must be ant igen(s) produced in the skin as a consequ ence of 
UVB exposure that trigger(s) the immune system a nd result(s) 
in the induction of regulatory T- Iymphocytes that suppress the 
rejection of UVB- induced tumors [21). Thus, for PUVA treat-
ment to induce tumor susceptibility by this same mechanism, 
it wou ld have to alter antigen presentation so that the suppres-
sor cell pathway could be triggered, a nd it would have to induce 
the formation of the same set of antigens as those induced 
during UVB exposure to provide the stimulus for the induction 
of suppressor cells with the same specificity. From these studies, 
we conclude that PUVA treatment does not induce precisely 
the same immunologic changes as those observed in UVB-
irradiated mice. This could result from the fa ilure of PUV A 
treatment to induce the alteration in antigen presentation that 
activates the suppressor cell pathway, the fa ilure of PUV A 
treatment to produce the same ant igens in the skin as those 
produced by UVB, or both. Studies to distinguish among these 
alterations by testing antigen presentation and suppressor cell 
induction in PUVA-treated animals and testing t he growth of 
PUVA-induced tumors in PUV A-treated and UVB-treated an-
imals cWTently are in progress. 
Thus, even though there are many similarities in t he biologic 
effects of UVB and PUV A treatment, these agents may differ 
with regard to theil' immunologic effects and/or in the immu-
nologic characteristics of th e skin t umors that they induce. This 
should not be interpreted as indicating that t here are differences 
in the risk of developing skin cancer from PUV A or UVB 
treatment, however, since t his point is not addressed by these 
studies. Furthermore, it would be premature at present to 
attempt to draw conclusions from these studies regarding the 
immunologic effects of PUV A a nd U VB treatment of human 
subjects. Due to the vast differences in skin archi tecture, con-
ditions of UV exposure, and dose and route of methoxsalen 
ad ministration between our experimental animals and human 
subj ects, it is not possible to assess the relevance of these 
immunologic findin gs for patients treated therapeut ically with 
PUV A or UVB radiation. 
We thank Mr. Jeffrey Linebaugh for his excellent technical assistance 
and Mr. Rox Anderson for measuring the radiation sources. 
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